Kindly MD, Inc.
NAKA
$0.89
-$0.04-4.41%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -36.08% | -30.07% | -20.48% | -25.47% | -34.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.08% | -30.07% | -20.48% | -25.47% | -34.75% |
| Cost of Revenue | 92.52% | 41.27% | -21.63% | 12.91% | -26.08% |
| Gross Profit | -457.42% | -480.76% | 772.73% | -241.44% | -18.84% |
| SG&A Expenses | 152.59% | 104.21% | 117.78% | 54.83% | 15.18% |
| Depreciation & Amortization | -42.80% | -28.51% | 115.71% | -1.54% | -1.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.03% | 52.07% | 53.21% | 22.94% | 6.04% |
| Operating Income | -130.57% | -339.35% | -238.50% | -105.20% | -72.49% |
| Income Before Tax | -82.91% | -267.69% | -208.25% | -96.87% | -121.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -82.91% | -267.69% | -208.25% | -96.87% | -121.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.91% | -267.69% | -208.25% | -96.87% | -121.28% |
| EBIT | -130.57% | -339.35% | -238.50% | -105.20% | -72.49% |
| EBITDA | -134.98% | -382.56% | -250.91% | -110.91% | -75.88% |
| EPS Basic | -34.43% | -182.00% | -140.37% | -49.78% | -96.86% |
| Normalized Basic EPS | -38.11% | -181.94% | -140.46% | -49.72% | -90.92% |
| EPS Diluted | -34.43% | -182.00% | -140.37% | -49.78% | -96.86% |
| Normalized Diluted EPS | -38.11% | -181.94% | -140.46% | -49.72% | -90.92% |
| Average Basic Shares Outstanding | 36.08% | 30.47% | 28.28% | 31.48% | 12.44% |
| Average Diluted Shares Outstanding | 36.08% | 30.47% | 28.28% | 31.48% | 12.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |